Salivary Biomarkers for Diagnosis and Therapy Monitoring in Patients with Heart Failure. A Systematic Review.
biomarkers
diagnosis
heart failure
saliva
therapy monitoring
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
02 May 2021
02 May 2021
Historique:
received:
01
04
2021
revised:
26
04
2021
accepted:
30
04
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
The aim of this study was to perform a systematic review on the potential value of saliva biomarkers in the diagnosis, management and prognosis of heart failure (HF). The correlation between saliva and plasma values of these biomarkers was also studied. PubMed was searched to collect relevant literature, i.e., case-control, cross-sectional studies that either compared the values of salivary biomarkers among healthy subjects and HF patients, or investigated their role in risk stratification and prognosis in HF patients. No randomized control trials were included. The search ended on 31st of December 2020. A total of 15 studies met the inclusion criteria. 18 salivary biomarkers were analyzed and the levels of all biomarkers studied were found to be higher in HF patients compared to controls, except for amylase, sodium, and chloride that had smaller saliva concentrations in HF patients. Natriuretic peptides are the most commonly used plasma biomarkers in the management of HF. Their saliva levels show promising results, although the correlation of saliva to plasma values is weakened in higher plasma values. In most of the publications, differences in biomarker levels between HF patients and controls were found to be statistically significant. Due to the small number of patients included, larger studies need to be conducted in order to facilitate the use of saliva biomarkers in clinical practice.
Identifiants
pubmed: 34063278
pii: diagnostics11050824
doi: 10.3390/diagnostics11050824
pmc: PMC8147430
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Horizon 2020 Framework Programme
ID : 768686
Références
IEEE Rev Biomed Eng. 2020;13:17-31
pubmed: 30892234
Heart Fail Clin. 2017 Jul;13(3):485-502
pubmed: 28602367
Clin Chem. 2009 Aug;55(8):1530-8
pubmed: 19556448
Proteomes. 2017 Aug 07;5(3):
pubmed: 28783097
J Clin Med. 2020 Mar 12;9(3):
pubmed: 32178375
J Periodontol. 2019 Jul;90(7):788-797
pubmed: 30536725
Lancet. 2000 Feb 5;355(9202):468-9
pubmed: 10841133
Pharmacoeconomics. 2020 Nov;38(11):1219-1236
pubmed: 32812149
Clin Chem Lab Med. 2018 Aug 28;56(9):1432-1442
pubmed: 29630504
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Aug;114(2):207-14
pubmed: 22769406
Asian Pac J Cancer Prev. 2019 Jul 01;20(7):2087-2093
pubmed: 31350970
J Am Coll Cardiol. 2001 Feb;37(2):412-7
pubmed: 11216955
Int J Cardiol. 2016 Jan 15;203:69-73
pubmed: 26492313
Heart Fail Rev. 2010 Jul;15(4):331-41
pubmed: 19363700
J Interferon Cytokine Res. 2003 Jun;23(6):329-33
pubmed: 12859859
J Clin Invest. 1950 Nov;29(11):1445-7
pubmed: 14794771
BMJ. 2018 May 21;361:k1450
pubmed: 29785952
Sci Rep. 2020 May 4;10(1):7441
pubmed: 32366899
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Expert Rev Mol Diagn. 2016;16(4):487-500
pubmed: 26788983
Circulation. 2007 Apr 3;115(13):1754-61
pubmed: 17372171
PLoS One. 2012;7(10):e48452
pubmed: 23119023
Sensors (Basel). 2019 Nov 16;19(22):
pubmed: 31744130
Circ Res. 2015 Mar 27;116(7):1254-68
pubmed: 25814686
Eur J Heart Fail. 2005 Mar 2;7(2):167-72
pubmed: 15701462
Circ Heart Fail. 2009 Nov;2(6):608-15
pubmed: 19919986
Curr Cardiol Rev. 2016;12(1):37-46
pubmed: 26750722
J Dent Res. 2014 Jul;93(7 Suppl):72S-79S
pubmed: 24879575
J Am Coll Cardiol. 2018 Jan 30;71(4):386-398
pubmed: 29389354
Indian Heart J. 2020 Jan - Feb;72(1):14-19
pubmed: 32423555
Auton Autacoid Pharmacol. 2002 Apr;22(2):83-92
pubmed: 12568125
Clin Microbiol Rev. 2013 Oct;26(4):781-91
pubmed: 24092855
Gastroenterol Clin North Am. 1990 Dec;19(4):793-810
pubmed: 1702756
Eur Heart J. 2004 Aug;25(16):1428-37
pubmed: 15321701
Eur J Prev Cardiol. 2015 Sep;22(9):1096-110
pubmed: 25268020
Theranostics. 2017 Sep 26;7(18):4350-4358
pubmed: 29158831
Curr Heart Fail Rep. 2014 Mar;11(1):70-9
pubmed: 24293034
Circulation. 2017 May 30;135(22):e1054-e1091
pubmed: 28446515
Eur J Heart Fail. 2004 Dec;6(7):883-90
pubmed: 15556050
Heart Fail Rev. 2021 Sep;26(5):1141-1150
pubmed: 32030562
Open Heart. 2018 Jul 11;5(2):e000819
pubmed: 30018779
SAGE Open Med. 2014 Dec;2:
pubmed: 26246898
Arch Cardiol Mex. 2018 Jul - Sep;88(3):171-177
pubmed: 28408177
Circ Heart Fail. 2013 Mar;6(2):219-26
pubmed: 23395934
Clin Exp Pharmacol Physiol. 2019 Mar;46(3):197-203
pubmed: 30372548
Eur J Heart Fail. 2016 Mar;18(3):242-52
pubmed: 26727047
N Engl J Med. 1990 Jul 26;323(4):236-41
pubmed: 2195340
Biol Res Nurs. 2017 Mar;19(2):153-161
pubmed: 27605566
Open Heart. 2017 Aug 21;4(2):e000639
pubmed: 28878953
Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:1382-1385
pubmed: 31946150
Clin Res Cardiol. 2020 Jun;109(6):685-692
pubmed: 31598750
Kardiol Pol. 2017;75(1):71-77
pubmed: 27296284
Clin Chim Acta. 2005 Sep;359(1-2):189-94
pubmed: 15904907
J Clin Pathol. 2016 Dec;69(12):1100-1104
pubmed: 27340130
Eur J Heart Fail. 2020 Mar;22(3):391-412
pubmed: 32133741
Braz J Med Biol Res. 2019;52(7):e8416
pubmed: 31314851
Circulation. 2018 Jan 16;137(3):286-297
pubmed: 29335288
Hellenic J Cardiol. 2018 Jul - Aug;59(4):193-195
pubmed: 30240846